This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are Investors Undervaluing Ceragon Networks (CRNT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Ceragon Networks (CRNT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights TIM, Ceragon and PLDT
by Zacks Equity Research
TIM eyes 5G dominance, Ceragon boosts network efficiency, and PLDT expands cable reach as non-U.S. wireless stocks tap rising global demand.
Ceragon Declines 44% in 6 Months: A Buying Opportunity for Investors?
by Zacks Equity Research
CRNT launches high-speed wireless tech and sees E2E bookings exceed expectations, but shares lag with 44% drop over six months.
3 Wireless Non-US Stocks Likely to Thrive on Industry Strength
by Supriyo Bose
TIMB, CRNT and PHI aim to ride the rising IoT and 5G demand, leveraging strong infrastructure, strategic expansion and long-term growth potential.
Ceragon Networks (CRNT) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Ceragon (CRNT) delivered earnings and revenue surprises of 50% and 2.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Amer Movil (AMX) Misses Q1 Earnings Estimates
by Zacks Equity Research
Amer Movil (AMX) delivered earnings and revenue surprises of -6.25% and 0.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Buy Ceragon Networks (CRNT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CRNT Tanks 50% in Three Months: Where Will the Stock Head From Here?
by Zacks Equity Research
Ceragon's exposure to India, as well as frequent product launches, holds promise, but the soft CSP market remains a concern.
CRNT Stock Down 28% in a Month: A Buying Opportunity or Caution Ahead?
by Vaishali Doshi
CRNT's focus on growth initiatives, including mmW products, Private Networks and Managed Services, holds promise, but the soft CSP market remains a concern.
Ceragon Expands Portfolio With New Product Launches at MWC 2025
by Zacks Equity Research
CRNT unveils breakthrough solutions like IP-100E, IP-50GP and EtherHaul 8020FX, redefining high-speed wireless connectivity.
Should Ceragon Stock be in Your Portfolio Post Q4 Earnings?
by Vaishali Doshi
CRNT's focus on growth initiatives, including mmW products, Private Networks and Managed Services, holds promise, but soft CSP market remains concern.
Ceragon Networks' Q4 Earnings Up Y/Y, Revenues Surpass Estimates
by Zacks Equity Research
CRNT Q4 revenues beat expectations while earnings miss. Both top and bottom lines increase year over year, driven by strong sales in India and EMEA segments.
Ceragon Networks (CRNT) Q4 Earnings Lag Estimates
by Zacks Equity Research
Ceragon (CRNT) delivered earnings and revenue surprises of -10% and 2.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Add Ceragon Stock to Your Portfolio Pre-Q4 Earnings?
by Vaishali Doshi
CRNT's Q4 performance is likely to have gained from higher demand. The slowdown of some public network domains outside of India and weak CSP ordering are concerns.
Ceragon (CRNT) Soars 11.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ceragon (CRNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRNT Stock Up 71% in 3 Months: Buy Now or Wait for a Pullback?
by Vaishali Doshi
Ceragon is witnessing growth in North America and India. Stiff competition from Chinese players in several regions and soft macro environment are concerns.
Can Ceragon Stock Benefit From End 2 End Technologies' Buyout?
by Zacks Equity Research
CRNT enters into a definitive agreement to acquire End 2 End Technologies, expanding its offering across North America.
Ceragon (CRNT) Moves 15.9% Higher: Will This Strength Last?
by Zacks Equity Research
Ceragon (CRNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Fast-paced Momentum Stock Ceragon (CRNT) Is Still Trading at a Bargain
by Zacks Equity Research
Ceragon (CRNT) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Ceragon Networks (CRNT) Is Up 11.40% in One Week: What You Should Know
by Zacks Equity Research
Does Ceragon Networks (CRNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Industry Outlook Highlights Vodafone Group, KT and Ceragon Networks
by Zacks Equity Research
Vodafone Group, KT and Ceragon Networks have been highlighted in this Industry Outlook article.
3 Wireless Non-US Stocks to Watch Amid Short-Term Industry Headwinds
by Supriyo Bose
The fast-track 5G rollout and solid wireless traction should help the Zacks Wireless Non-US industry thrive despite short-term headwinds. VOD, KT and CRNT are well-positioned to make the most of the demand for seamless connectivity solutions.
Here's Why Ceragon (CRNT) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Ceragon (CRNT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Why Fast-paced Mover Ceragon (CRNT) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Ceragon (CRNT) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.